aspergillomarasmine a has been researched along with phosphoramidon in 1 studies
Studies (aspergillomarasmine a) | Trials (aspergillomarasmine a) | Recent Studies (post-2010) (aspergillomarasmine a) | Studies (phosphoramidon) | Trials (phosphoramidon) | Recent Studies (post-2010) (phosphoramidon) |
---|---|---|---|---|---|
17 | 0 | 15 | 781 | 12 | 33 |
Protein | Taxonomy | aspergillomarasmine a (IC50) | phosphoramidon (IC50) |
---|---|---|---|
Thermolysin | Bacillus thermoproteolyticus | 0.033 | |
Neprilysin | Rattus norvegicus (Norway rat) | 0.0578 | |
Neprilysin | Oryctolagus cuniculus (rabbit) | 0.0028 | |
Neprilysin | Homo sapiens (human) | 0.0405 | |
Angiotensin-converting enzyme | Homo sapiens (human) | 0.615 | |
Endothelin-converting enzyme 1 | Homo sapiens (human) | 1.0695 | |
P2Y purinoceptor 12 | Homo sapiens (human) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, K; Asakura, R; Ashikawa, N; Ashizawa, N; Kobayashi, F; Matsuura, A; Okumura, H; Takahashi, M | 1 |
1 other study(ies) available for aspergillomarasmine a and phosphoramidon
Article | Year |
---|---|
Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors.
Topics: Animals; Aorta; Aspartic Acid; Aspartic Acid Endopeptidases; Cattle; Edetic Acid; Endothelin-Converting Enzymes; Endothelins; Endothelium, Vascular; Glycopeptides; Hypertension; In Vitro Techniques; Lethal Dose 50; Male; Metalloendopeptidases; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley | 1993 |